Synonyms: BI-1265162 | example 2.04 [WO2017028927A1]
Compound class:
Synthetic organic
Comment: We obtained this structure from a list compiled by DrugHunter of first time disclosures made at the 2021 XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC). The structure mapped to a PubChem entry that was submitted by SureChEMBL in 2017 as an extraction from Bohringer Ingelhiem's patent WO2017028927A1 [3]. The EFMC-ISMC discosure provided the BI1265162 name-to-structure association. BI1265162 was developed as an inhibitor of the endothelial sodium channel (ENaC), whose excessive activity in cystic fibrosis contributes to the production of hyperconcentrated mucus [5]. It is described as a 'direct inhibitor' of ENaC in a review by Mall (2020) [5].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel